Ligand validation:4GZT

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4GZT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4GZT_NAG_B_508	46%	37%	0.154	0.888	0.6	1.82	-	4	0	0	100%	0.9333
4GZT_NAG_A_510	39%	44%	0.176	0.88	0.49	1.66	-	2	1	0	100%	0.9333
4GZT_NAG_C_509	25%	42%	0.257	0.893	0.51	1.72	-	2	1	0	100%	0.9333
4GZT_NAG_B_509	21%	29%	0.243	0.852	0.51	2.3	-	3	0	0	100%	0.9333
4GZT_NAG_D_512	19%	38%	0.268	0.865	0.55	1.84	-	5	1	0	100%	0.9333
4GZT_NAG_B_507	16%	46%	0.268	0.835	0.55	1.49	-	2	0	0	100%	0.9333
4GZT_NAG_A_509	13%	35%	0.351	0.891	0.81	1.74	1	3	0	0	100%	0.9333
4GZT_NAG_D_507	8%	29%	0.314	0.781	0.61	2.18	-	2	0	0	100%	0.9333
4GZW_NAG_C_811	37%	61%	0.202	0.898	0.48	0.99	-	1	0	0	100%	0.9333
6BR6_NAG_A_501	34%	63%	0.128	0.807	0.73	0.68	-	1	0	0	100%	0.9333
4GZQ_NAG_A_509	23%	47%	0.229	0.854	0.46	1.56	-	1	0	0	100%	0.9333
4GZX_NAG_A_809	21%	48%	0.183	0.792	0.54	1.45	-	3	1	0	100%	0.9333
4GZO_NAG_A_508	18%	53%	0.254	0.845	0.63	1.19	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333
5U7O_NAG_B_704	100%	88%	0.024	0.989	0.23	0.44	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.